A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 130 participants.
Also called NCT06925750
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT06925750 -
2024-518687-12-00 -
U1111-1314-0614 -
jRCT2061250021
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Australia, Canada, China, Colombia, Czechia, France, Hungary, Israel, Italy, Japan, Netherlands, Singapore, South Korea, Spain, Taiwan, Thailand, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06925750. Allocation not applicable; no masking; primary purpose treatment. Start 2025-05-12 (actual); primary completion 2028-06-16 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
- Acronym
- LIGHTRAY EXT
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Biological)
- Sotatercept
- Intervention (Drug)
- Background PAH Therapy
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct06925750- Content hash
e4c97f8d85290224d01df14b739affd809f8994e8dcf3c13e6111967a7d6d1a3